The efficacy of intranasal interferon alpha-2a in respiratory syncytial virus infection in volunteers

In a double-blind, placebo-controlled study, self-administered intranasal interferon alpha-2a or placebo was given both before and after challenge with respiratory syncytial virus. The incidence of colds and the severity of signs and symptoms were reduced in those receiving interferon alpha-2a as compared with those given placebo. In a further double-blind, placebo-controlled study, self-administered interferon alpha-2a or placebo was given only to those volunteers who developed colds following challenge with respiratory syncytial virus. There was no evidence that interferon alpha-2a reduced the severity of the signs and symptoms or shortened the duration of the illness. The similarity of these results to the effect of interferon alpha-2a in rhinovirus infections in volunteers is discussed.     

Action spectra for human skin cells: estimates of the relative cytotoxicity of the middle ultraviolet, near ultraviolet, and violet regions of sunlight on epidermal keratinocytes

Action spectra for the cytotoxic action of electromagnetic radiation in the solar range 280-434 nm have been determined for human fibroblasts and epidermal keratinocytes derived from the same foreskin biopsy. The spectra for the two cell types are close to identical and coincide with our previously published data for a human lymphoblastoid line indicating that the mechanism of inactivation of the three human cell types is similar at any given wavelength. Using published data for ultraviolet transmission of human skin and sample spectral irradiance data, we have estimated the relative biological effectiveness of the middle ultraviolet (UVB) (290-320 nm), near ultraviolet (UVA) (320-380 nm), and violet (380-434 nm) regions of sunlight for cytotoxicity at the basal layer of the epidermis. We conclude that the UVB component in noon summer sunlight (the most UVB rich spectral conditions tested) may contribute only about 40% of the total cytotoxic effectiveness of sunlight at 290-434 nm. At lower zenith angles, UVA can account for up to 80% of the cytotoxic effectiveness of the combined UVA and UVB regions. Finally, a comparison of published action spectra data for human erythema with cytotoxicity data corrected for ultraviolet transmission to different depths of the human epidermis suggests that UVA erythema could be causally related to cytotoxicity occurring at an average depth of 40-50 micron into the human epidermis.     

The effects of severe visual challenges on steering performance in visually healthy young drivers.

PURPOSE: Two experiments explored the extent to which induced blur, reduced luminance, and reduced visual fields affect drivers' steering performance in a driving simulator. METHODS: In experiment 1, ten young participants (M = 21.2 years) drove at approximately 89 km/h (55 mph) along a curvy roadway while being exposed to blur (0 to + 10 D), luminance (0.003 to 16.7 cd/m), and visual field (1.7 and 150 degrees) manipulations. In experiment 2, a new group of ten young participants (M = 18.5 years) drove while exposed to seven visual field sizes (1.7 to 150 degrees). RESULTS: Steering was sensitive to a reduced field size but not to the blur and luminance challenges. Acuity, on the other hand, was sensitive to the blur and luminance challenges but not to reduced field size. DISCUSSION: In healthy young drivers, steering performance is remarkably robust to severe blur and to extremely low luminances. These results support a key element of the selective degradation hypothesis advanced by Leibowitz and colleagues--that steering abilities are preserved at night even when the ability to recognize objects and hazards is not. Additional research should address the other element of this hypothesis--that drivers fail to appreciate the extent to which their visual abilities are degraded at night.     

Acute coronary syndromes

The first 150 words of the full text of this article appear below. Key points Coronary artery disease accounts for >30% ofdeaths in Western society. The diagnosis of myocardial infarctionshould be qualified by size, causation and time from occurrence. Mortalityis reduced by immediate or ‘primary’ percutaneouscoronary intervention or thrombolysis within the first 24 hof onset of ST-segment elevation myocardial infarction. Strategiesto reduce platelet activation (glycoprotein IIb/IIIa receptorantagonists, or clopidogrel) are now recommended in the treatmentof high-risk non-ST-segment myocardial infarction/unstable angina. Elevatedserum troponins may be the result of non-ischaemic myocardialdamage, especially in critical illness.